Advertisement

Coxsackievirus B Epidemiology and Public Health Concerns

  • M. A. Pallansch
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 223)

Abstract

The coxsackieviruses group B (CVB) are members of the genus Enterovirus and share many properties with other members of this group. There are several excellent reviews covering the basic epidemiology and clinical characteristics of enteroviruses and their infections (MOdlin 1990; Morens et al. 1991; MElnick 1996), and this material will not be repeated in detail except as it relates to recent studies. Most of the conclusions concerning enteroviruses in general are directly applicable to CVB, including: pronounced seasonality in temperate climates; geographic, age, and sex distribution; high incidence and prevalence; moderately high transmission; and most clinical syndromes.

Keywords

Amyotrophic Lateral Sclerosis Chronic Fatigue Syndrome Aseptic Meningitis Chronic Fatigue Syndrome Patient Acute Flaccid Paralysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alexander JP Jr, Chapman LE, Pallansch MA, Stephenson WT, Torok TJ, Anderson LJ (1993) Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team. J Infect Dis 167:1201–1205PubMedCrossRefGoogle Scholar
  2. Argo E, Gimenez B, Cash P (1992) Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus. Arch Virol 126:215–229PubMedCrossRefGoogle Scholar
  3. Axelsson C, Bondestam K, Frisk G, Bergstrom S, Diderholm H (1993) Coxsackie B virus infections in women with miscarriage. J Med Virol 39:282–285PubMedCrossRefGoogle Scholar
  4. Barrett-Conner E (1985) Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence. Rev Infect Dis 7:207–215CrossRefGoogle Scholar
  5. Bartfeld H, Dham C, Donnenfeld H, Ollar RA, deMasi MT, Kascsak R (1989) Enteroviral-related antigen in circulating immune complexes of amyotrophic lateral sclerosis patients. Intervirology 30:202–212PubMedGoogle Scholar
  6. Beck MA, Chapman NM, McManus BM, Mullican JC, Tracy S (1990) Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects. Am J Pathol 136:669–681Google Scholar
  7. Beck MA, Kolbeck PC, Rohr LH, Shi Q, Morris VC, Levander OA (1994a) Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice. J Nutr 124:345–358PubMedGoogle Scholar
  8. Beck MA, Kolbeck PC, Shi Q, Rohr LH, Morris VC, Levander OA (1994b) Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice. J Infect Dis 170:351–357PubMedCrossRefGoogle Scholar
  9. Bell EJ, McCartney RA (1984) A study of coxsackie B virus infections, 1972-1983. J Hyg (Lond) 93:197–204CrossRefGoogle Scholar
  10. Berlin LE, Rorabaugh ML, Heldrich F, Roberts K, Doran T, Modlin JF (1993) Aseptic meningitis in infants < 2 years of age: diagnosis and etiology. J Infect Dis 168:888–892PubMedCrossRefGoogle Scholar
  11. Boman J, Nilsson B, Juto P (1992) Serum IgA, IgG, and IgM responses to different enteroviruses as measured by a coxsackie B5-based indirect ELISA. J Med Virol 38:32–35PubMedCrossRefGoogle Scholar
  12. Bowles NE, Rose ML, Taylor P, Banner NR, Morgan-Capner P, Cunningham L, Archard LC, Yacoub MH (1989) End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 80:1128–1136PubMedCrossRefGoogle Scholar
  13. Cochrane HR, May FE, Ashcroft T, Dark JH (1991) Enteroviruses and idiopathic dilated cardiomyopathy. J Pathol 163:129–131PubMedCrossRefGoogle Scholar
  14. Cunningham L, Bowles NE, Lane RJ, Dubowitz V, Archard LC (1990) Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J Gen Virol 71:1399–1402PubMedCrossRefGoogle Scholar
  15. D’Alessio DJ (1992) A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 135:1331–1338PubMedGoogle Scholar
  16. Dahlquist G, Frisk G, Ivarsson SA, Svanberg L, Forsgren M, Diderholm H (1995) Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 38:1371–1373PubMedCrossRefGoogle Scholar
  17. Day C, Cumming H, Walker J (1989) Enterovirus-specific IgM in the diagnosis of meningitis. J Infect 19:219–228PubMedCrossRefGoogle Scholar
  18. Drebot MA, Nguan CY, Campbell J J, Lee SH, Forward KR (1994) Molecular epidemiology of enterovirus outbreaks in Canada during 1991-1992: identification of echovirus 30 and coxsackievirus B1 strains by amplicon sequencing. J Med Virol 44:340–347PubMedCrossRefGoogle Scholar
  19. Druyts-Voets E, VanRenterghem L, Gerniers S (1993) Coxsackie B virus epidemiology and neonatal infection in Belgium. J Infect 27:311–316PubMedCrossRefGoogle Scholar
  20. Fohlman J, Friman G (1993) Is juvenile diabetes a viral disease?Ann Med 25:569–574PubMedGoogle Scholar
  21. Fohlman J, Ilback NG, Friman G, Morein B (1990) Vaccination of Balb/c mice against enteroviral mediated myocarditis. Vaccine 8:381–384PubMedCrossRefGoogle Scholar
  22. Fohlman J, Pauksen K, Morein B, Bjare U, Ilback NG, Friman G (1993) High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand J Infect Dis Suppl 88:103–108PubMedGoogle Scholar
  23. Frisk G, Diderholm H (1992) Increased frequency of coxsackie B virus IgM in women with spontaneous abortion. J Infect 24:141–145PubMedCrossRefGoogle Scholar
  24. Frisk G, Friman G, Tuvemo T, Fohlman J, Diderholm H (1992) Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Diabetologia 35:249–253PubMedCrossRefGoogle Scholar
  25. Frisk G, Nilsson E, Ehrnst A, Diderholm H (1989) Enterovirus IgM detection: specificity of mu-antibody-capture radioimmunoassays using virions and procapsids of Coxsackie B virus. J Virol Methods 24:191–202PubMedCrossRefGoogle Scholar
  26. Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, Crawley R (1995) Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol 154:2983–2995PubMedGoogle Scholar
  27. Goldwater PN (1995) Immunoglobulin M capture immunoassay in investigation of coxsackievirus B5 and B6 outbreaks in South Australia. J Clin Microbiol 33:1628–1631PubMedGoogle Scholar
  28. Gomez RM, Cui X, Castagnino CG, Berria MI (1993) Differential behaviour in pancreas and heart of two coxsackievirus B3 variants. Intervirology 36:153–160PubMedGoogle Scholar
  29. Gow J, Cash P, Behan W, McGarry F, Simpson K, Behan P (1995) Detection of picornavirus genomic and template RNA strands by a novel semi-nested polymerase chain reaction-technique and agarosegel electrophoresis. Electrophoresis 16:338–340PubMedCrossRefGoogle Scholar
  30. Grandien M, Forsgren M, Ehrnst A (1989) Enteroviruses and reoviruses. In: Schmidt NJ, Emmons RW (eds), Diagnostic procedures for viral, rickettsial and chlamydial infections. American Public Health Association, Washington, DC, pp 513–569Google Scholar
  31. Haarmann CM, Schwimmbeck PL, Mertens T, Schultheiss HP, Strauer BE (1994) Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology 200:381–389PubMedCrossRefGoogle Scholar
  32. Haddad J, Gut JP, Wendling MJ, Astruc D, Jernite M, Obert G, Messer J (1993) Enterovirus infections in neonates. A retrospective study of 21 cases. Eur J Med 2:209–214PubMedGoogle Scholar
  33. Helfand RF, Gary HE Jr, Freeman CY, Anderson LJ, Pallansch MA (1995) Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group. J Infect Dis 172:1206–1211Google Scholar
  34. Hilton DA, Fletcher A, Pringle JH (1994) Absence of coxsackie viruses in idiopathic inflammatory muscle disease by in situ hybridization. Neuropathol Appl Neurobiol 20:238–242PubMedCrossRefGoogle Scholar
  35. Hodgson J, Bendig J, Keeling P, Booth JC (1995) Comparison of two immunoassay procedures for detecting enterovirus IgM. J Med Virol 47:29–34PubMedCrossRefGoogle Scholar
  36. Hohenadl C, Klingel K, Mertsching J, Hofschneider PH, Kandolf R (1991) Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Mol Cell Probes 5:11–20PubMedCrossRefGoogle Scholar
  37. Hu H, Dong D, Tang E, Zhang M, Cao Y (1993) Antigenic analysis of coxsackievirus B3 with monoclonal antibodies. Jpn J Med Sci Biol 46:87–93PubMedGoogle Scholar
  38. Hyoty H, Hiltunen M, Knip M, Laakkonen M, Vahasalo P, Karjalainen J, Koskela P, Roivainen M, Leinikki P, Hovi T, Akerblom HK, Childhood Diabetes in Finland (DiMe) Study Group (1995) A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 44:652–657PubMedCrossRefGoogle Scholar
  39. Ikeda RM, Kondracki SF, Drabkin PD, Birkhead GS, Morse DL (1993) Pleurodynia among football players at a high school.An outbreak associated with coxsackievirus Bl. JAMA 270:2205–2206PubMedCrossRefGoogle Scholar
  40. Ilback NG, Wesslen L, Pauksen K, Stalhandske T, Friman G, Fohlman J (1993) Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/TNF and gamma-interferon responses during viral heart disease. Scand J Infect Dis Suppl 88:117–123PubMedGoogle Scholar
  41. Isacsohn M, Eidelman AI, Kaplan M, Goren A, Rudensky B, Handsher R, Barak Y (1994) Neonatal coxsackievirus group B infections: experience of a single department of neonatology. Isr J Med Sci 30:371–374PubMedGoogle Scholar
  42. Kamei S, Hersch SM, Kurata T, Takei Y (1990) Coxsackie B antigen in the central nervous system of a patient with fatal acute encephalitis: immunohistochemical studies of formalin-fixed paraffin-embedded tissue. Acta Neuropathol (Berl) 80:216–221CrossRefGoogle Scholar
  43. Kaplan MH, Klein SW, McPhee J, Harper RG (1983) Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 5:1019–1032PubMedCrossRefGoogle Scholar
  44. Keeling PJ, Lukaszyk A, Poloniecki J, Caforio AL, Davies MJ, Booth JC, McKenna WJ (1994) A prospective case-control study of antibodies to coxsackie B virus in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 23:593–598PubMedCrossRefGoogle Scholar
  45. Kew O, De L, Yang CF, Nottay B, daSilva E, Pallansch M (1993) The role of virological surveillance in the global initiative to eradicate poliomyelitis. In: Kurstak E (ed), Control of virus diseases. Marcel Dekker, New York, pp 215–246Google Scholar
  46. Kew OM, Mulders MN, Lipskaya GY, daSilva EE, Pallansch MA (1995) Molecular epidemiology of polioviruses. In: Kew O, Nathanson N (eds), Molecular epidemiology. Seminars in Virology, vol 6. Academic, New York, pp 401–414Google Scholar
  47. Kopecka H, Brown B, Pallansch M (1995) Genotypic variation in coxsackievirus B5 isolates from three different outbreaks in the United States. Virus Res 38:125–136PubMedCrossRefGoogle Scholar
  48. Landau BJ, Whittier PS, Finkelstein SD, Alstein B, Grun JB, Schultz M, Crowell RL (1990) Induction of heterotypic virus resistance in adult inbred mice immunized with a variant of Coxsackievirus B3. Microb Pathog 8:289–298PubMedCrossRefGoogle Scholar
  49. Lerner AM, Wilson FM (1973) Virus myocardiopathy. Prog Med Virol 15:63–91PubMedGoogle Scholar
  50. Melnick JL (1996) Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. Fields BN Knipe DM Howley PM Chanock RM Melnick JL Monath TP Roizman B Straus SE , Virology. Lippincott-Raven, Philadelphia, pp 655–712Google Scholar
  51. Miller NA, Carmichael HA, Calder BD, Behan PO, Bell EJ, McCartney RA, Hall FC (1991) Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome. BMJ 302(6769) 140–143PubMedCrossRefGoogle Scholar
  52. Modlin JF (1990) Coxsackieviruses, echoviruses, and newer enteroviruses. Mandell GL Douglas RG Jr, Bennett JE ,Principles and practices of infectious diseases. Churchill Livingstone, New York, pp 1367–1383Google Scholar
  53. Moreira RC, Castrignano SB, Carmona R de C. Gomes FM, Saes SG, Oliveira RS, Souza DF, Takimoto S, Costa MC, Waldman EA(1995) An exanthematic disease epidemic associated with coxsackievirus B3 infection in a day care center. Rev Inst Med Trop Sao Paulo 37:235–238PubMedCrossRefGoogle Scholar
  54. Moore M (1982) Enteroviral disease in the United States, 1970-1979. J Infect Dis 146:103–108PubMedCrossRefGoogle Scholar
  55. Morens DM, Zweighaft RM, Bryan JM (1979) Non-polio enterovirus disease in the United States, 1971-1975. Int J Epidemiol 8:49–54PubMedCrossRefGoogle Scholar
  56. Morens DM, Pallansch MA, Moore M (1991) Polioviruses and other enteroviruses. Belshe RB , Textbook of Human Virology. Mosby Year Book, St Louis, Missouri, pp 427–497Google Scholar
  57. Muir P, Banatvala JE (1990) Reactivity of enterovirus-specific IgM with infective and defective coxsackie B virions in patients with monotypic and multitypic IgM responses. J Virol Methods 29:209–224PubMedCrossRefGoogle Scholar
  58. Muir P, Nicholson F, Tilzey AJ, Signy M, English TA, Banatvala JE (1989) Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet 1(8642)804–807PubMedCrossRefGoogle Scholar
  59. Nairn C, Galbraith DN, Clements GB (1995) Comparison of coxsackie B neutralisation and enteroviral PCR in chronic fatigue patients. J Med Virol 46:310–313PubMedCrossRefGoogle Scholar
  60. Nakayama T, Urano T, Osano M, Hayashi Y, Sekine S, Ando T, Makinom S (1989) Outbreak of herpangina associated with coxsackievirus B3 infection. Pediatr Infect Dis J 8:495–498PubMedCrossRefGoogle Scholar
  61. Nishikai M (1994) Coxsackievirus infection and the development of polymyositis/dermatomyositis. Rheumatol Int 14:43–46PubMedCrossRefGoogle Scholar
  62. Pauksen K, Ilback NG, Friman G, Fohlman J (1993) Therapy of coxsackie virus B3-induced myocarditis with WIN 54954 in different formulations. Scand J Infect Dis Suppl 88:125–130PubMedGoogle Scholar
  63. Prabhakar BS, Haspel MV, McClintock PR, Notkins AL (1982) High frequency of antigenic variants among naturally occurring human coxsackie B4 virus isolates identified by monoclonal antibodies. Nature 300:374–376PubMedCrossRefGoogle Scholar
  64. Prabhakar BS, Menegus MA, Notkins AL (1985) Detection of conserved and nonconserved epitopes on Coxsackievirus B4: frequency of antigenic change. Virology 146:302–306PubMedCrossRefGoogle Scholar
  65. Rabausch-Starz I, Schwaiger A, Griinewald K, Muller-Hermelink HK, Neu N (1994) Persistence of virus and viral genome in myocardium after coxsackievirus B3-induced murine myocarditis. Clin Exp Immunol 96:69–74PubMedCrossRefGoogle Scholar
  66. Reyes MP, Zalenski D, Smith F, Wilson FM, Lerner AM (1986) Coxsackievirus-positive cervices in women with febrile illnesses during the third trimester in pregnancy. Am J Obstet Gynecol 155:159–161PubMedGoogle Scholar
  67. Rozhon E, Cox S, Buontempo P, O’Connell J, Slater W, DeMartino J, Schwartz J, Miller G, Arnold E, Zhang A., Morrow C, Jablonski S, Pinto P, Versace R, Duelfer T, Girijavallabhan V (1993) SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating. Antiviral Res 21:15–35PubMedCrossRefGoogle Scholar
  68. Samuelson A, Forsgren M, Johansson B, Wahren B, Sallberg M (1994) Molecular basis for serological cross-reactivity between enteroviruses. Clin Diagn Lab Immunol 1:336–341PubMedGoogle Scholar
  69. Satoh M, Tamura G, Segawa I, Hiramori K, Satodate R (1994) Enteroviral RNA in dilated cardiomyopathy. Eur Heart J 15:934–939PubMedGoogle Scholar
  70. Scherbaum WA, Hampl W, Muir P, Gluck M, Seißler J, Egle H, Hauner H, Boehm BO, Heinze E, BanatvalaJE, Pfeiffer EF (1991) No association between islet cell antibodies and Coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7-19 years. Diabetologia 34:835–838PubMedCrossRefGoogle Scholar
  71. Schwaiger A, Umlauft F, Weyrer K, Larcher C, Lyons J, Muhlberger V, Dietze O, Griinewald K (1993) Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction. Am Heart J 126:406–410PubMedCrossRefGoogle Scholar
  72. See DM, Tilles JG (1993) WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus. Antimicrob Agents Chemother 37:1593–1598PubMedGoogle Scholar
  73. See DM, Tilles JG (1994) Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses. Scand J Infect Dis 26:739–747PubMedCrossRefGoogle Scholar
  74. Severini GM, Mestroni L, Falaschi A, Camerini F, Giacca M (1993) Nested polymerase chain reaction for high-sensitivity detection of enteroviral RNA in biological samples. J Clin Microbiol 31:1345–1349PubMedGoogle Scholar
  75. Shimizu H, Schnurr DP, Burns JC (1994) Comparison of methods to detect enteroviral genome in frozen and fixed myocardium by polymerase chain reaction. Lab Invest 71:612–616PubMedGoogle Scholar
  76. Strikas RA, Anderson LJ, Parker RA (1986) Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970 -1983. J Infect Dis 153:346–351PubMedCrossRefGoogle Scholar
  77. Strong BS, Young SA (1995) Intrauterine coxsackie virus, group B type 1, infection: viral cultivation from amniotic fluid in the third trimester. Am J Perinatol 12:78–79PubMedCrossRefGoogle Scholar
  78. Swanink CM, Veenstra L, Poort YA, Kaan JA, Galama JM (1993) Coxsackievirus B1-based antibodycapture enzyme-linked immunosorbent assay for detection of immunoglobulin G (IgG), IgM, and IgA with broad specificity for enteroviruses. J Clin Microbiol 31:3240–3246PubMedGoogle Scholar
  79. Szopa TM, Ward T, Dronfield DM, Portwood ND, Taylor KW (1990) Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates. Diabetologia 33:325–328PubMedCrossRefGoogle Scholar
  80. Takada H, Kishimoto C, Hiraoka Y (1995) Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects. Circulation 92:1604–1611PubMedGoogle Scholar
  81. Tam PE, Schmidt AM, Ytterberg SR, Messner RP (1991) Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis. J Virol 65:6654–6660PubMedGoogle Scholar
  82. Tonew M, Hartmann M, Schmidtke M, Stelzner A (1995) Replication and persistence of coxsackieviruses B3 in human fibroblasts. Int J Med Microbiol Virol Parasitol Infect Dis 282:92–101Google Scholar
  83. Tracy S, Chapman N, Romero J, Ramsingh A (1996) Coxsackievirus B3 cardiovirulence determinants and their role in inflammatory heart muscle disease. Trends in Microbiology 4:175–178PubMedCrossRefGoogle Scholar
  84. Tracy S, Hufnagel G, Chapman N (1992) Interesting problems in enteroviral inflammatory heart disease. Herz 17:79–84PubMedGoogle Scholar
  85. Tracy S, Chapman NM, McManus BM, Pallansch MA, Beck MA, Carstens J (1990) A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol 22:403–114PubMedCrossRefGoogle Scholar
  86. Tu Z, Chapman NM, Hufnagel G, Tracy S, Romero JR, Barry WH, Zhao L, Currey K, Shapiro B (1995) The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5’ nontranslated region. J Virol 69:4607–1618PubMedGoogle Scholar
  87. Tuvemo T, Dahlquist G, Frisk G, Blom L, Friman G, Landin-Olsson M, Diderholm H (1989) The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children - no evidence of increased antibody frequency. Diabetologia 32:745–747PubMedCrossRefGoogle Scholar
  88. Wagenknecht LE, Roseman JM, Herman WH (1991) Increased incidence of insulin-dependent diabetes mellitus following an epidemic of Coxsackievirus B5. Am J Epidemiol 133:1024–1031PubMedGoogle Scholar
  89. Webb SR, Kearse KP, Foulke CL, Hartig PC, Prabhakar BS (1986) Neutralization epitope diversity of Coxsackievirus B4 isolates detected by monoclonal antibodies. J Med Virol 20:9–15PubMedCrossRefGoogle Scholar
  90. Weiss LM, Movahed LA, Billingham ME, Cleary ML (1991) Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. Am J Pathol 138:497–503PubMedGoogle Scholar
  91. Weller AH, Hall M, Huber SA (1992) Polyclonal immunoglobulin therapy protects against cardiac damage in experimental coxsackievirus-induced myocarditis. Eur Heart J 13:115–119PubMedGoogle Scholar
  92. Wesslen L, Waldenstrom A, Lindblom B, Hoyer S, Friman G, Fohlman J (1993) Genotypic and serotype profile in dilated cardiomyopathy. Scand J Infect Dis Suppl 88:87–91PubMedGoogle Scholar
  93. Woodall CJ, Riding MH, Graham DI, Clements GB (1994) Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease. BMJ 308:1541–1543PubMedGoogle Scholar
  94. Yagi S, Schnurr D, Lin J (1992) Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies. J Clin Microbiol 30:2498–2501PubMedGoogle Scholar
  95. Yui LA, Gledhill RF (1991) Limb paralysis as a manifestation of Coxsackie B virus infection. Dev Med Child Neurol 33:427–438PubMedCrossRefGoogle Scholar
  96. Zoll J, Galama J, Melchers W (1994) Intratypic genome variability of the coxsackievirus B1 2 A protease region. J Gen Virol 75:687–692PubMedCrossRefGoogle Scholar
  97. Zoll J, Jongen P, Galama J, vanKuppeveld F, Melchers W (1993) Coxsackievirus B1-induced murine myositis: no evidence for viral persistence. J Gen Virol 74:2071–2076PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • M. A. Pallansch
    • 1
  1. 1.Division of Viral and Rickettsial DiseasesNational Center for Infectious Diseases, Centers for Disease Control and PreventionAtlantaUSA

Personalised recommendations